DDX53 and colorectal carcinoma: To assess the effect of CRC-EVs on macrophage efferocytosis, BMDMs were treated with 10 μg/ml of CT26-EVs for 24 h, and then co-cultured with apoptotic CT26 cells at a ratio of 1:3 for 4 h.